2015 International Symposium on Cancer Immunotherapy: Featuring Today's Innovators, Tomorrow's Leaders
Organized in collaboration with the World Immunotherapy Council (WIC), the 2015 International Symposium on Cancer Immunotherapy provided the opportunity for young scientists and emerging leaders in the field of cancer immunotherapy from throughout the world to interact, fulfilling WIC’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.
The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, contributed fresh insight and perspective into present and future issues surrounding immunotherapy of cancer (including immune targeting, escape, monitoring and treatments). Anticipated challenges and projected improvements as cancer immunotherapy is integrated into mainstream cancer treatment were also highlighted. Additionally, this forum provided a unique opportunity to showcase the world’s young, talented cancer immunotherapy scientists and provided an opportunity for knowledge exchange and networking with established experts.
The target audience for this program consisted of clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals from academic institutions, industry and regulatory agencies who wished to learn more about the future of cancer immunotherapy research across the globe.
To learn more, click here to download reports from the Symposium.
2012 World Immunotherapy Council Summit in Curacao
In an exciting and first-of-its-kind collaboration, SITC convened the World Immunotherapy Council (WIC) inaugural summit February 21-24, 2012 in Curacao. Scientific sessions at the meeting focused on several of the hurdles identified in the "Defining the Critical Hurdles in Cancer Immunotherapy" manuscript (see above), including mechanisms of immune escape, immunological monitoring, and prognostic and predictive biomarkers. This summit provided a forum to facilitate the rapid development and global dissemination of cancer immunotherapies through international scientific exchange.